Categories: HealthcareNews

Nemaura Medical to Present at the Planet MIcroCap Showcase: Virtual 2022

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

Loughborough, England, Dec. 01, 2022 (GLOBE NEWSWIRE) — Nemaura Medical, Inc. (Nasdaq: NMRD), a medical technology company focused on developing and commercializing noninvasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, announces today that CEO Dr. Faz Chowdhury will present a corporate overview at the Planet MicroCap Showcase: Virtual 2022 being held on December 6 – 8, 2022.

Presentation Date: December 7, 2022
Time: 9:00am EST
Webcast Link: https://www.webcaster4.com/Webcast/Page/2937/47190

Dr. Chowdhury will be available for one-on-one investor meetings throughout the conference. To attend the conference and request a meeting, register here:

https://planetmicrocapshowcase.com/signup

About Nemaura Medical, Inc.

Nemaura Medical, Inc. is a medical technology company developing and commercializing non-invasive wearable diagnostic devices. The company is currently commercializing sugarBEAT® and proBEAT. sugarBEAT®, a CE mark approved Class IIb medical device, is a non-invasive and flexible continuous glucose monitor (CGM) providing actionable insights derived from real time glucose measurements and daily glucose trend data, which may help people with diabetes and pre-diabetes to better manage, reverse, and prevent the onset of diabetes. Nemaura has submitted a PMA (Premarket Approval Application) for sugarBEAT® to the U.S. FDA. proBEAT combines non-invasive glucose data processed using artificial intelligence and a digital healthcare subscription service and has been launched in the U.S. as a general wellness product as part of its BEAT®diabetes program that is currently undergoing pilot studies.

The Company sits at the intersection of the global Type 2 diabetes market that is expected to reach nearly $59 billion by 2025, the $50+ billion pre-diabetic market, and the wearable health-tech sector for weight loss and wellness applications that is estimated to reach $60 billion by 2023.

For more information, please visit www.NemauraMedical.com.

Contact:

Jules Abraham (Media)
CORE IR
917-885-7378
julesa@coreir.com

Bret Shapiro (Investors)
Senior Managing Partner
CORE IR
(561) 479.8566
brets@coreir.com

Staff

Recent Posts

Eyemart Express Teams Up with “The Jennifer Hudson Show” to Encourage Young Readers

Partnership launches a summer digital series that celebrates the joy of reading DALLAS, June 24,…

59 minutes ago

ZEISS Solves Industry Challenges at Tech Days Event

ZEISS Industry Tech Days brings together manufacturers across five states to show how advanced metrology…

59 minutes ago

A Glimpse Into the Future of Mass Spectrometry: Game-Changing Technologies and Transformative Trends Unveiled at ASMS 2025

ARLINGTON, Va., June 24, 2025 /PRNewswire/ -- Behind the doors of the ASMS 2025 conference, held…

59 minutes ago

Circulogene Launches LungLifeAI® Nationally Through Primary Care Channel

PENSACOLA, Fla., June 24, 2025 /PRNewswire/ -- Circulogene, a leading provider of precision diagnostics for…

59 minutes ago

LevelJump Announces Revocation of Cease Trade Order; Seeking Reinstatement of Trading On TSX Venture Exchange

Toronto, Ontario--(Newsfile Corp. - June 24, 2025) - LevelJump Healthcare Corp. - (TSXV: JUMP) ("LevelJump" or the "Company") is…

5 hours ago

AllianceHCM Appoints Alan Primeaux as Chief Executive Officer to Propel Next Phase of Growth

HOUSTON, June 24, 2025 /PRNewswire/ -- AllianceHCM, one of the nation's leading privately held providers…

7 hours ago